19940 Federal Register / Vol. 87, No. 66 / Wednesday, April 6, 2022 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics 

(BSC, NCHS) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Board of Scientific Counselors, 

National Center for Health Statistics 

BSC, NCHS). This meeting is open to 

the public. Time will be available for 

public comment. 

DATES: The meeting will be held on May 

26, 2022, from 11:00 a.m. to 5:30 p.m., 

EDT (times subject to change). 

ADDRESSES: Instructions to access the 

meeting will be posted here: https://

www.cdc.gov/nchs/about/bsc/bsc_

meetings.htm. 

FOR FURTHER INFORMATION CONTACT: 

Rebecca Hines, M.H.S., Executive 

Secretary, NCHS/CDC, Board of 

Scientific Counselors, 3311 Toledo 

Road, Room 2627, Hyattsville, Maryland 

20782, Telephone: (301) 458–4717; 

Email: RSHines@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Board is charged with 

providing advice and making 

recommendations to the Secretary, 

Department of Health and Human 

Services; the Director, CDC; and the 

Director, NCHS, regarding the scientific 

and technical program goals and 

objectives, strategies, and priorities of 

NCHS. 

Matters to be Considered: The 

meeting agenda will include welcome 

remarks and a Center update by the 

NCHS Director; an update on CDC’s 

Data Modernization Initiative (DMI) and 

DMI-funded projects at NCHS; a report 

out from the Population Health Survey 

Planning, Methodology and Data 

Presentation (PHSPMDP) Workgroup on 

their assessment of the use of panel 

survey data by NCHS, and; a report out 

from the new Workgroup to Consider 

and Assess Measures of Discrimination 

for use in NCHS surveys. 

The Board will reserve time for public 

comment at the end of the day. Agenda 

items are subject to change as priorities 

dictate. 

Meeting Information: Please visit the 

BSC website for details: https://

www.cdc.gov/nchs/about/bsc/bsc_

meetings.htm. 

Further information and the meeting 

agenda will be available on the BSC 

website including instructions for 

accessing the live meeting broadcast. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–07242 Filed 4–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–OH–22–002, Panel A and Panel C, 

NIOSH Centers for Agricultural Safety 

and Health. 

Dates and Times: May 9–10, 2022, 

Panel A, 11:00 a.m.–6:00 p.m., EDT; and 

May 11–12, 2022, Panel C, 11:00 a.m.– 

6:00 p.m., EDT. 

Place: Video-Assisted Meeting. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Marilyn Ridenour, B.S.N., M.B.A., 

M.P.H., C.P.H., C.I.C., CAPT, USPHS, 

Scientific Review Officer, Office of 

Extramural Programs, National Institute 

for Occupational Safety and Health, 

CDC, 1095 Willowdale Road, 

Morgantown, West Virginia 26505, 

Telephone: (304) 285–5879; Email: 

MRidenour@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–07244 Filed 4–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Healthcare 

Infection Control Practices Advisory 

Committee (HICPAC) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

HICPAC. The HICPAC consists of 14 

experts in fields including but not 

limited to, infectious diseases, infection 

prevention, healthcare epidemiology, 

nursing, clinical microbiology, surgery, 

hospitalist medicine, internal medicine, 

epidemiology, health policy, health 

services research, public health, and 

related medical fields. Nominations are 

being sought for individuals who have 

expertise and qualifications necessary to 

contribute to the accomplishments of 

the committee’s objectives. Nominees 

will be selected based on expertise in 

the fields of infectious diseases, 

infection prevention, healthcare 

epidemiology, nursing, environmental 

and clinical microbiology, surgery, 

internal medicine, and public health. 

Federal employees will not be 

considered for membership. Members 

may be invited to serve for four-year 

terms. Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of HICPAC 

objectives https://www.cdc.gov/hicpac/. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 66 / Wednesday, April 6, 2022 / Notices 19941 

DATES: Nominations for membership on 

the HICPAC should be received no later 

than September 17, 2022. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

mailed to HICPAC, Division of 

Healthcare Quality Promotion, NCEZID, 

CDC, 1600 Clifton Road NE, Mailstop 

H16–3, Atlanta, Georgia 30329–4027, 

emailed (recommended) to hicpac@

cdc.gov, or faxed to (404) 639–4043. 

FOR FURTHER INFORMATION CONTACT: 

Sydnee Byrd, MPA, HICPAC, Division 

of Healthcare Quality Promotion, 

NCEZID, CDC, 1600 Clifton Road NE, 

Mailstop H16–3, Atlanta, Georgia 

30329–4027; Telephone: (404) 718– 

8039, Email: hicpac@cdc.gov. 

SUPPLEMENTARY INFORMATION: The U.S. 

Department of Health and Human 

Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented, and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, it is HHS policy 

is to avoid excessive individual service 

on advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees (SGEs), requiring the filing 

of financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for HICPAC membership each year and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in July 2023, or as 

soon as the HHS selection process is 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. Candidates should 

submit the following items: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address) 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

(Candidates may submit letter(s) from 

current HHS employees if they wish, 

but at least one letter must be submitted 

by a person not employed by an HHS 

agency (e.g., CDC, NIH, FDA, etc.). 

Nominations may be submitted by the 

candidate him- or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–07236 Filed 4–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Public Health Determination and Order 

Regarding Suspending the Right To 

Introduce Certain Persons From 

Countries Where a Quarantinable 

Communicable Disease Exists 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: General notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), a 

component of the U.S. Department of 

Health and Human Services (HHS), is 

hereby issuing this Public Health 

Determination and Order Regarding 

Suspending the Right to Introduce 

Certain Persons from Countries Where a 

Quarantinable Communicable Disease 

Exists (Public Health Determination and 

Termination). This Public Health 

Determination and Termination 

terminates the Order Suspending the 

Right to Introduce Certain Persons from 

Countries Where a Quarantinable 

Communicable Disease Exists, issued on 

August 2, 2021 (August Order), and all 

related prior orders issued pursuant to 

the authorities in sections 362 and 365 

of the Public Health Service (PHS) Act 

and implementing regulations. This 

Termination will be implemented on 

May 23, 2022. 

DATES: The Termination issued in this 

Order will be implemented on May 23, 

2022. 

FOR FURTHER INFORMATION CONTACT: 

Candice Swartwood, Division of Global 

Migration and Quarantine, National 

Center for Emerging and Zoonotic 

Infectious Diseases, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, MS H16–4, Atlanta, GA 

30329. Telephone: 404–498–1600. 

Email: dgmqpolicyoffice@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

Coronavirus disease 2019 (COVID–19) 

is a quarantinable communicable 

disease caused by the SARS–CoV–2 

virus. As part of U.S. government efforts 

to mitigate the introduction, 

transmission, and spread of COVID–19, 

CDC issued the August Order, replacing 

a prior order issued on October 13, 

2020, which continued a series of orders 

issued pursuant to 42 U.S.C. 265, 268 

and the implementing regulation at 42 

CFR 71.40, suspending the right to 

introduce certain persons into the 

United States from countries or places 

where the quarantinable communicable 

disease exists in order to protect the 

public health from an increased risk of 

the introduction of COVID–19 (CDC 

Orders). 

The CDC Orders issued under 42 

U.S.C. 265, 268 and 42 CFR 71.40 were 

intended to reduce the risk of COVID– 

19 introduction, transmission, and 

spread at ports of entry (POE) and U.S. 

Border Patrol stations by significantly 

reducing the number and density of 

covered noncitizens held in these 

congregate settings, thereby reducing 

risks to U.S. citizens and residents, 

Department of Homeland Security and 

U.S. Customs and Border Patrol 

personnel and noncitizens at the 

facilities, and local healthcare systems. 

CDC deemed the measures included in 

the CDC Orders necessary for the 

protection of public health during the 

ongoing COVID–19 pandemic. 

The August Order applied specifically 

to ‘‘covered noncitizens,’’ defined as 

‘‘persons traveling from Canada or 

Mexico (regardless of their country of 

origin) who would otherwise be 

introduced into a congregate setting in 

a POE or U.S. Border Patrol station at or 

near the U.S. land and adjacent coastal 

borders subject to certain exceptions 

detailed below; this includes 

noncitizens who do not have proper 

travel documents, noncitizens whose 

entry is otherwise contrary to law, and 

noncitizens who are apprehended at or 

near the border seeking to unlawfully 

enter the United States between POE.’’ 


lotter on DSK11XQN23PROD with NOTICES1